## Background: Controlled-release (cr) morphine tablets have become routine therapy in the management of cancer pain. compared with immediate-release (ir) morphine, this formulation provides the benefit of dosing every 12 hours. ## Methods: This study reviewed the 10 published, well controlled, r
β¦ LIBER β¦
Controlled release morphine tablets: a double-blind trial in patients with advanced cancer
β Scribed by G. W. HANKS; R. G. TWYCROSS; J. M. BLISS
- Book ID
- 108619899
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 341 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0003-2409
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Controlled-release morphine tablets in p
β
Carol A. Warfield
π
Article
π
1998
π
John Wiley and Sons
π
English
β 143 KB
π 2 views
Pharmacokinetics and clinical efficacy o
β
Michael P. Thirlwell; Paul A. Sloan; Jean A. Maroun; Gerry J. Boos; Jean-Guy Bes
π
Article
π
1989
π
John Wiley and Sons
π
English
β 835 KB
Near fatal intoxication with controlled-
β
D. Westerling; J. SΓ€we; G. Eklundh
π
Article
π
1998
π
John Wiley and Sons
π
English
β 381 KB
Analgesic response to single and multipl
β
Barry R. Goughnour; William W. Arkinstall; John H. Stewart
π
Article
π
1989
π
John Wiley and Sons
π
English
β 441 KB
π 1 views
Immediate-release oral morphine, given every four hours in individually titrated doses, is effective in the control of severe cancer pain. To evaluate the analgesic efficacy of a controlled-release morphine sulfate preparation, MS Contin tablets (MSC, Purdue Frederick, Toronto, Ontario, Canada), aft
Rufinamide: a double-blind, placebo-cont
β
Sven PΓ₯lhagen; Raffaele Canger; Olaf Henriksen; Johan A. van Parys; Marie-Emmanu
π
Article
π
2001
π
Elsevier Science
π
English
β 105 KB
Toremifene and tamoxifen in advanced bre
β
Lars E. Stenbygaard; JΓΈrn Herrstedt; Jane F. Thomsen; Karsten R. Svendsen; Svend
π
Article
π
1993
π
Springer US
π
English
β 463 KB